Neuroprotective effects of bone morphogenetic protein 7 (BMP7) treatment after spinal cord injury

Neuroscience Letters

Volumn 465, Issue 3, 2009, Pages 226-229

  de Rivero Vaccari, Juan Pablo ^a   Marcillo, Alex ^a   Nonner, Doris ^a   Dietrich, W Dalton ^a   Keane, Robert W ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Bone morphogenetic protein 7; Glutamate excitotoxicity; MAPK signaling; Spinal cord injury

Indexed keywords

GLUTAMIC ACID; MITOGEN ACTIVATED PROTEIN KINASE P38; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; OSTEOGENIC PROTEIN 1;

ADULT ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; DISEASE SEVERITY; EXCITOTOXICITY; FEMALE; GENE EXPRESSION; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD INJURY; SPINAL CORD VENTRAL HORN;

ANIMALS; BONE MORPHOGENETIC PROTEIN 7; CELL SURVIVAL; CERVICAL VERTEBRAE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MAP KINASE SIGNALING SYSTEM; NEURONS; NEUROPROTECTIVE AGENTS; RATS; RATS, INBRED F344; RECEPTORS, N-METHYL-D-ASPARTATE; SPINAL CORD INJURIES; TREATMENT OUTCOME;

EID: 70349973444     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.09.013     Document Type: Article

References (35)

1. Benardete E.A., and Bergold P.J. Genomic analysis of ischemic preconditioning in adult rat hippocampal slice cultures. Brain Res. (2009)
2. Bramlett H.D., D W., Alonso O., and Green E.J. Effect of bone morphogentic protein-7 (BMP-7) treatment on behavior after traumatic brain injury in rats. Int. J. Neuroprot. Neuroregener. 1 (2005) 165-170
3. Brown K.M., Wrathall J.R., Yasuda R.P., and Wolfe B.B. Glutamate receptor subunit expression after spinal cord injury in young rats. Brain Res. 152 (2004) 61-68
4. Chang C.F., Lin S.Z., Chiang Y.H., Morales M., Chou J., Lein P., Chen H.L., Hoffer B.J., and Wang Y. Intravenous administration of bone morphogenetic protein-7 after ischemia improves motor function in stroke rats. Stroke 34 (2003) 558-564
5. Charytoniuk D.A., Traiffort E., Pinard E., Issertial O., Seylaz J., and Ruat M. Distribution of bone morphogenetic protein and bone morphogenetic protein receptor transcripts in the rodent nervous system and up-regulation of bone morphogenetic protein receptor type II in hippocampal dentate gyrus in a rat model of global cerebral ischemia. Neuroscience 100 (2000) 33-43
6. Chaverneff F., and Barrett J. Casein kinase II contributes to the synergistic effects of BMP7 and BDNF on Smad 1/5/8 phosphorylation in septal neurons under hypoglycemic stress. J. Neurochem. 109 (2009) 733-743
7. Chou J., Harvey B.K., Chang C.F., Shen H., Morales M., and Wang Y. Neuroregenerative effects of BMP7 after stroke in rats. J. Neurol. Sci. 240 (2006) 21-29
8. Cox S., Harvey B.K., Sanchez J.F., Wang J.Y., and Wang Y. Mediation of BMP7 neuroprotection by MAPK and PKC IN rat primary cortical cultures. Brain Res. 1010 (2004) 55-61
9. Dumont R.J., Okonkwo D.O., Verma S., Hurlbert R.J., Boulos P.T., Ellegala D.B., and Dumont A.S. Acute spinal cord injury. Part I. Pathophysiologic mechanisms. Clin. Neuropharmacol. 24 (2001) 254-264
10. Enzmann G.U., Benton R.L., Woock J.P., Howard R.M., Tsoulfas P., and Whittemore S.R. Consequences of noggin expression by neural stem, glial, and neuronal precursor cells engrafted into the injured spinal cord. Exp. Neurol. 195 (2005) 293-304
11. Esquenazi S., Monnerie H., Kaplan P., and Le Roux P. BMP-7 and excess glutamate: opposing effects on dendrite growth from cerebral cortical neurons in vitro. Exp. Neurol. 176 (2002) 41-54
12. Faden A.I., Demediuk P., Panter S.S., and Vink R. The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 244 (1989) 798-800
13. Gazzerro E., and Minetti C. Potential drug targets within bone morphogenetic protein signaling pathways. Curr. Opin. Pharmacol. 7 (2007) 325-333
14. Haddad J.J. N-Methyl-d-aspartate (NMDA) and the regulation of mitogen-activated protein kinase (MAPK) signaling pathways: a revolving neurochemical axis for therapeutic intervention?. Prog. Neurobiol. 77 (2005) 252-282
15. Haghighi S.S., Agrawal S.K., Surdell Jr. D., Plambeck R., Agrawal S., Johnson G.C., and Walker A. Effects of methylprednisolone and MK-801 on functional recovery after experimental chronic spinal cord injury. Spinal Cord 38 (2000) 733-740
16. Harvey B.K., Hoffer B.J., and Wang Y. Stroke and TGF-beta proteins: glial cell line-derived neurotrophic factor and bone morphogenetic protein. Pharmacol. Ther. 105 (2005) 113-125
17. Hu M.C., Wasserman D., Hartwig S., and Rosenblum N.D. p38MAPK acts in the BMP7-dependent stimulatory pathway during epithelial cell morphogenesis and is regulated by Smad1. J. Biol. Chem. 279 (2004) 12051-12059
18. Jantas D., and Lason W. Different mechanisms of NMDA-mediated protection against neuronal apoptosis: a stimuli-dependent effect. Neurochem. Res. (2009)
19. Kawamata T., Ren J., Chan T.C., Charette M., and Finklestein S.P. Intracisternal osteogenic protein-1 enhances functional recovery following focal stroke. Neuroreport 9 (1998) 1441-1445
20. Kawamoto J.C., and Barrett J.N. Cryopreservation of primary neurons for tissue culture. Brain Res. 384 (1986) 84-93
21. Kumar A., Zou L., Yuan X., Long Y., and Yang K. N-Methyl-d-aspartate receptors: transient loss of NR1/NR2A/NR2B subunits after traumatic brain injury in a rodent model. J. Neurosci. Res. 67 (2002) 781-786
22. Lewen A., Soderstrom S., Hillered L., and Ebendal T. Expression of serine/threonine kinase receptors in traumatic brain injury. Neuroreport 8 (1997) 475-479
23. McAdoo D.J., Hughes M.G., Xu G.Y., Robak G., and de Castro Jr. R. Microdialysis studies of the role of chemical agents in secondary damage upon spinal cord injury. J. Neurotrauma 14 (1997) 507-515
24. Miyazono K., Maeda S., and Imamura T. BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev. 16 (2005) 251-263
25. Nesic O., Svrakic N.M., Xu G.Y., McAdoo D., Westlund K.N., Hulsebosch C.E., Ye Z., Galante A., Soteropoulos P., Tolias P., Young W., Hart R.P., and Perez-Polo J.R. DNA microarray analysis of the contused spinal cord: effect of NMDA receptor inhibition. J. Neurosci. Res. 68 (2002) 406-423
26. Nicole O., Ali C., Docagne F., Plawinski L., MacKenzie E.T., Vivien D., and Buisson A. Neuroprotection mediated by glial cell line-derived neurotrophic factor: involvement of a reduction of NMDA-induced calcium influx by the mitogen-activated protein kinase pathway. J. Neurosci. 21 (2001) 3024-3033
27. Nonner D., Barrett E.F., Kaplan P., and Barrett J.N. Bone morphogenetic proteins (BMP6 and BMP7) enhance the protective effect of neurotrophins on cultured septal cholinergic neurons during hypoglycemia. J. Neurochem. 77 (2001) 691-699
28. Regan R.F., and Choi D.W. The effect of NMDA, AMPA/kainate, and calcium channel antagonists on traumatic cortical neuronal injury in culture. Brain Res. 633 (1994) 236-242
29. Ren J., Kaplan P.L., Charette M.F., Speller H., and Finklestein S.P. Time window of intracisternal osteogenic protein-1 in enhancing functional recovery after stroke. Neuropharmacology 39 (2000) 860-865
30. Repici M., Mare L., Colombo A., Ploia C., Sclip A., Bonny C., Nicod P., Salmona M., and Borsello T. c-Jun N-terminal kinase binding domain-dependent phosphorylation of mitogen-activated protein kinase kinase 4 and mitogen-activated protein kinase kinase 7 and balancing cross-talk between c-Jun N-terminal kinase and extracellular signal-regulated kinase pathways in cortical neurons. Neuroscience 159 (2009) 94-103
31. Ryu B.R., Ko H.W., Jou I., Noh J.S., and Gwag B.J. Phosphatidylinositol 3-kinase-mediated regulation of neuronal apoptosis and necrosis by insulin and IGF-I. J. Neurobiol. 39 (1999) 536-546
32. Setoguchi T., Yone K., Matsuoka E., Takenouchi H., Nakashima K., Sakou T., Komiya S., and Izumo S. Traumatic injury-induced BMP7 expression in the adult rat spinal cord. Brain Res. 921 (2001) 219-225
33. Tamaki K., Souchelnytskyi S., Itoh S., Nakao A., Sampath K., Heldin C.H., and ten Dijke P. Intracellular signaling of osteogenic protein-1 through Smad5 activation. J. Cell. Physiol. 177 (1998) 355-363
34. Timmer J., Chesnutt C., and Niswander L. The activin signaling pathway promotes differentiation of dI3 interneurons in the spinal neural tube. Dev. Biol. 285 (2005) 1-10
35. Zwijsen A., Verschueren K., and Huylebroeck D. New intracellular components of bone morphogenetic protein/Smad signaling cascades. FEBS Lett. 546 (2003) 133-139